Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Shibata

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|March 6, 2012
Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulationYasuyuki Morikawa, Hidekazu Koike, Yoshitaka Sekine, et al.
Cancer Detection and Prevention|April 10, 2007
Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in JapanYoshitaka Sekine, Kazuto Ito, Takumi Yamamoto, et al.
World Journal of Urology|August 21, 2012
Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL rangeKazuto Ito, Mai Miyakubo, Yoshitaka Sekine, et al.
Steroids|December 15, 2010
Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissuesSeiji Arai, Yoshimichi Miyashiro, Yasuhiro Shibata, et al.
Endocrinology|July 3, 2004
Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivoYasuhiro Shibata, Bunzo Kashiwagi, Seiji Arai, et al.
Prostate International|November 14, 2013
Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancerKazumichi Muramatsu, Hiroshi Matsui, Yoshitaka Sekine, et al.
Biochemical and Biophysical Research Communications|April 21, 2022
A gain-of-function mutation in the acid-sensing ion channel 2a induces marked cerebellar maldevelopment in ratsYasuhiro Shibata, Natsuko Kumamoto, Eisuke Sakuma, et al.
Arzneimittel-Forschung|October 28, 2011
Suppressive effects of the antiandrogen agent, chlormadinone acetate and the 5alpha-reductase inhibitor, dutasteride on prostate weight and intraprostatic androgen levels in ratsHideo Kobayashi, Kotaro Gotanda, Yasuhiro Shibata, et al.
Elife|May 1, 2025
GPRC6A as a novel kokumi receptor responsible for enhanced taste preferences by ornithineTakashi Yamamoto, Kayoko Ueji, Haruno Mizuta, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 12, 2019
Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screeningKazuto Ito, Ryo Oki, Yoshitaka Sekine, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|March 6, 2012
Rapamycin enhances docetaxel-induced cytotoxicity in a androgen-independent prostate cancer xenograft model by survivin downregulationYasuyuki Morikawa, Hidekazu Koike, Yoshitaka Sekine, et al.
Cancer Detection and Prevention|April 10, 2007
Pretreatment total testosterone levels in patients with prostate cancer in the past two decades in JapanYoshitaka Sekine, Kazuto Ito, Takumi Yamamoto, et al.
World Journal of Urology|August 21, 2012
Diagnostic significance of [-2]pro-PSA and prostate dimension-adjusted PSA-related indices in men with total PSA in the 2.0-10.0 ng/mL rangeKazuto Ito, Mai Miyakubo, Yoshitaka Sekine, et al.
Steroids|December 15, 2010
Effect of castration monotherapy on the levels of adrenal androgens in cancerous prostatic tissuesSeiji Arai, Yoshimichi Miyashiro, Yasuhiro Shibata, et al.
Endocrinology|July 3, 2004
Direct regulation of prostate blood flow by vascular endothelial growth factor and its participation in the androgenic regulation of prostate blood flow in vivoYasuhiro Shibata, Bunzo Kashiwagi, Seiji Arai, et al.
Prostate International|November 14, 2013
Androgen receptor coactivator p120 subtype β is highly expressed in prostate cancerKazumichi Muramatsu, Hiroshi Matsui, Yoshitaka Sekine, et al.
Biochemical and Biophysical Research Communications|April 21, 2022
A gain-of-function mutation in the acid-sensing ion channel 2a induces marked cerebellar maldevelopment in ratsYasuhiro Shibata, Natsuko Kumamoto, Eisuke Sakuma, et al.
Arzneimittel-Forschung|October 28, 2011
Suppressive effects of the antiandrogen agent, chlormadinone acetate and the 5alpha-reductase inhibitor, dutasteride on prostate weight and intraprostatic androgen levels in ratsHideo Kobayashi, Kotaro Gotanda, Yasuhiro Shibata, et al.
Elife|May 1, 2025
GPRC6A as a novel kokumi receptor responsible for enhanced taste preferences by ornithineTakashi Yamamoto, Kayoko Ueji, Haruno Mizuta, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|June 12, 2019
Screening for prostate cancer: History, evidence, controversies and future perspectives toward individualized screeningKazuto Ito, Ryo Oki, Yoshitaka Sekine, et al.
Pageof 9